Cargando…
A novel prognostic time window based on conditional survival and outcomes analyses of primary liver cancer patients
BACKGROUND: Liver cancer is one of the most deadly and prevalent cancers. A routine follow‐up plan for liver cancer is crucial but limited. In the present study, we aimed to disclose possible risk factors and critical survival time windows for primary liver cancer. METHODS: We enrolled 692 liver can...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582677/ https://www.ncbi.nlm.nih.gov/pubmed/35460212 http://dx.doi.org/10.1002/cam4.4762 |
_version_ | 1784812895624757248 |
---|---|
author | Lu, Weicheng Hong, Weifeng Qiu, Haibo Zhou, Zhongguo He, Zhonglian Zeng, Weian Zhong, Weiqiang Xie, Jingdun |
author_facet | Lu, Weicheng Hong, Weifeng Qiu, Haibo Zhou, Zhongguo He, Zhonglian Zeng, Weian Zhong, Weiqiang Xie, Jingdun |
author_sort | Lu, Weicheng |
collection | PubMed |
description | BACKGROUND: Liver cancer is one of the most deadly and prevalent cancers. A routine follow‐up plan for liver cancer is crucial but limited. In the present study, we aimed to disclose possible risk factors and critical survival time windows for primary liver cancer. METHODS: We enrolled 692 liver cancer patients from Sun Yat‐sen University Cancer Center (SYSUCC). Univariate and multivariate logistic regression analyses of cirrhosis and recurrence were conducted. A meta‐analysis was utilized to validate an indication of creatinine (CRE) in recurrence. Conditional survival analysis was performed using the Kaplan–Meier method. The results were further verified by the SYSUCC validation cohort and Surveillance, Epidemiology, and End Results (SEER) validation cohort. RESULTS: Our results indicated that A/G, history of hepatitis, history of alcohol consumption and platelet (PLT) might be potential prognostic factors for cirrhosis in liver cancer patients. CRE was significantly correlated with recurrence due to various therapies, especially after transarterial embolization. Moreover, 1.5 years to 2 years may be a critical time window for deterioration in survival rate based on the conditional survival analysis. CONCLUSION: A/G, history of hepatitis, alcohol consumption and PLT may be potential prognostic factors for cirrhosis in liver cancer patients. More attention should be focused on the renal function when treating the patients due to the significant role of CRE. 1.5 years to 2 years is a critical time window for deterioration in survival rate for liver cancer patients that contributes to determining the optimal follow‐up plan in the future. |
format | Online Article Text |
id | pubmed-9582677 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95826772022-10-21 A novel prognostic time window based on conditional survival and outcomes analyses of primary liver cancer patients Lu, Weicheng Hong, Weifeng Qiu, Haibo Zhou, Zhongguo He, Zhonglian Zeng, Weian Zhong, Weiqiang Xie, Jingdun Cancer Med RESEARCH ARTICLES BACKGROUND: Liver cancer is one of the most deadly and prevalent cancers. A routine follow‐up plan for liver cancer is crucial but limited. In the present study, we aimed to disclose possible risk factors and critical survival time windows for primary liver cancer. METHODS: We enrolled 692 liver cancer patients from Sun Yat‐sen University Cancer Center (SYSUCC). Univariate and multivariate logistic regression analyses of cirrhosis and recurrence were conducted. A meta‐analysis was utilized to validate an indication of creatinine (CRE) in recurrence. Conditional survival analysis was performed using the Kaplan–Meier method. The results were further verified by the SYSUCC validation cohort and Surveillance, Epidemiology, and End Results (SEER) validation cohort. RESULTS: Our results indicated that A/G, history of hepatitis, history of alcohol consumption and platelet (PLT) might be potential prognostic factors for cirrhosis in liver cancer patients. CRE was significantly correlated with recurrence due to various therapies, especially after transarterial embolization. Moreover, 1.5 years to 2 years may be a critical time window for deterioration in survival rate based on the conditional survival analysis. CONCLUSION: A/G, history of hepatitis, alcohol consumption and PLT may be potential prognostic factors for cirrhosis in liver cancer patients. More attention should be focused on the renal function when treating the patients due to the significant role of CRE. 1.5 years to 2 years is a critical time window for deterioration in survival rate for liver cancer patients that contributes to determining the optimal follow‐up plan in the future. John Wiley and Sons Inc. 2022-04-22 /pmc/articles/PMC9582677/ /pubmed/35460212 http://dx.doi.org/10.1002/cam4.4762 Text en © 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | RESEARCH ARTICLES Lu, Weicheng Hong, Weifeng Qiu, Haibo Zhou, Zhongguo He, Zhonglian Zeng, Weian Zhong, Weiqiang Xie, Jingdun A novel prognostic time window based on conditional survival and outcomes analyses of primary liver cancer patients |
title | A novel prognostic time window based on conditional survival and outcomes analyses of primary liver cancer patients |
title_full | A novel prognostic time window based on conditional survival and outcomes analyses of primary liver cancer patients |
title_fullStr | A novel prognostic time window based on conditional survival and outcomes analyses of primary liver cancer patients |
title_full_unstemmed | A novel prognostic time window based on conditional survival and outcomes analyses of primary liver cancer patients |
title_short | A novel prognostic time window based on conditional survival and outcomes analyses of primary liver cancer patients |
title_sort | novel prognostic time window based on conditional survival and outcomes analyses of primary liver cancer patients |
topic | RESEARCH ARTICLES |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582677/ https://www.ncbi.nlm.nih.gov/pubmed/35460212 http://dx.doi.org/10.1002/cam4.4762 |
work_keys_str_mv | AT luweicheng anovelprognostictimewindowbasedonconditionalsurvivalandoutcomesanalysesofprimarylivercancerpatients AT hongweifeng anovelprognostictimewindowbasedonconditionalsurvivalandoutcomesanalysesofprimarylivercancerpatients AT qiuhaibo anovelprognostictimewindowbasedonconditionalsurvivalandoutcomesanalysesofprimarylivercancerpatients AT zhouzhongguo anovelprognostictimewindowbasedonconditionalsurvivalandoutcomesanalysesofprimarylivercancerpatients AT hezhonglian anovelprognostictimewindowbasedonconditionalsurvivalandoutcomesanalysesofprimarylivercancerpatients AT zengweian anovelprognostictimewindowbasedonconditionalsurvivalandoutcomesanalysesofprimarylivercancerpatients AT zhongweiqiang anovelprognostictimewindowbasedonconditionalsurvivalandoutcomesanalysesofprimarylivercancerpatients AT xiejingdun anovelprognostictimewindowbasedonconditionalsurvivalandoutcomesanalysesofprimarylivercancerpatients AT luweicheng novelprognostictimewindowbasedonconditionalsurvivalandoutcomesanalysesofprimarylivercancerpatients AT hongweifeng novelprognostictimewindowbasedonconditionalsurvivalandoutcomesanalysesofprimarylivercancerpatients AT qiuhaibo novelprognostictimewindowbasedonconditionalsurvivalandoutcomesanalysesofprimarylivercancerpatients AT zhouzhongguo novelprognostictimewindowbasedonconditionalsurvivalandoutcomesanalysesofprimarylivercancerpatients AT hezhonglian novelprognostictimewindowbasedonconditionalsurvivalandoutcomesanalysesofprimarylivercancerpatients AT zengweian novelprognostictimewindowbasedonconditionalsurvivalandoutcomesanalysesofprimarylivercancerpatients AT zhongweiqiang novelprognostictimewindowbasedonconditionalsurvivalandoutcomesanalysesofprimarylivercancerpatients AT xiejingdun novelprognostictimewindowbasedonconditionalsurvivalandoutcomesanalysesofprimarylivercancerpatients |